Clinton Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,984
Closed -$756K 400
2018
Q2
$756K Sell
6,984
-2,151
-24% -$234K 0.12% 230
2018
Q1
$967K Buy
+9,135
New +$1.06M 0.1% 228
2017
Q4
Sell
-2,040
Closed -$232K 522
2017
Q3
$232K Sell
2,040
-24,976
-92% -$2.88M 0.03% 348
2017
Q2
$3.37M Buy
+27,016
New +$3.2M 0.34% 97
2015
Q4
Sell
-23,334
Closed -$2.13M 895
2015
Q3
$2.13M Sell
23,334
-38,617
-62% -$3.87M 0.2% 150
2015
Q2
$6.57M Buy
61,951
+58,846
+1,895% +$6.51M 0.92% 9
2015
Q1
$354K Buy
+3,105
New +$354K 0.09% 323
2014
Q3
Sell
-2,649
Closed -$267K 500
2014
Q2
$267K Buy
+2,649
New +$258K 0.13% 259

Other funds holding ZBH

Clinton Group's ZBH Position: Q3 2018 in Review

Clinton Group sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 6,984 shares — an estimated $756K sold.

Clinton Group first reported a position in ZBH in Q2 2014 and held it in 8 quarters. The position peaked at $6.57M in Q2 2015. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

  • Clinton Group reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 6,984 Zimmer Biomet shares in Q3 2018, an estimated $756K.
  • Clinton Group first reported a position in Zimmer Biomet in Q2 2014 and held it in 8 quarters.
  • Clinton Group's Zimmer Biomet position peaked at $6.57M in Q2 2015.
  • 891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.